Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling
Main Authors: | M Connock, C Stevens, A Fry-Smith, S Jowett, D Fitzmaurice, D Moore, F Song |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2007-10-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta11380 |
Similar Items
-
Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review
by: DA Lane, et al.
Published: (2013-07-01) -
A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1
by: M Connock, et al.
Published: (2006-06-01) -
Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review
by: Mohammad Al Mukdad BPharm, et al.
Published: (2019-05-01) -
Systematic review of cost-effectiveness analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation
by: João Ferreira, et al.
Published: (2015-03-01) -
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for atrial fibrillation in PortugalCost-effectiveness of new oral anticoagulants in Portuguese atrial fibrillation patients
by: João Costa, et al.
Published: (2015-12-01)